New publisher announced for Journal Of Pharmaceutical Sciences

December 06, 1999

The American Chemical Society will discontinue its joint publishing arrangement for the Journal of Pharmaceutical Sciences, effective on December 31, 1999, it was announced today. The American Pharmaceutical Association, which established this journal in 1927 and has published it jointly with ACS since 1993, will continue publishing the journal with John Wiley & Sons, Inc., beginning January 1.

Over the last six years ACS has enhanced the journal by adding many features, including an electronic version, and reducing the time to publish through the Articles As Soon As Publishable (ASAP) function. APhA now reassumes total responsibility for publishing a journal that is recognized as pre-eminent in the field.

The electronic archive of journal articles will be available through Wiley Interscience ( in January 2000. Based on its participation in the Digital Object Identifier (DOI) project, ACS anticipates that all bookmarks that make use of the DOI address will continue to be valid after the transition is complete.
For further information regarding this publication transfer, please contact Susan Spilka, 212-850-6147,, at John Wiley & Sons Inc.

A nonprofit organization with a membership of nearly 159,000 chemists and chemical engineers, the American Chemical Society publishes scientific journals and databases, convenes major research conferences, and provides educational, science policy and career programs in chemistry. Its main offices are in Washington, D.C., and Columbus, Ohio. (

American Chemical Society

Related Pharmaceutical Sciences Articles from Brightsurf:

GARDP partners with Japanese pharmaceutical in pursuit of new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) has today announced an agreement with Daiichi Sankyo for GARDP to access and screen the Daiichi Sankyo chemical library.

The integrated catalysts can simplify pharmaceutical manufacturing
Prof. In Su Lee and his research team from POSTECH developed catalytic platforms based on metal organic frameworks.

Study: Pharmaceutical companies marketing stimulants to physicians
Results of a new study show that a large number of physicians in the US may have received marketing payments from pharmaceutical companies that produce stimulant medications.

3D printing with applications in the pharmaceutical industry
This achievement will have applications in the pharmaceutical industry, such as in the preparation of biocompatible biosensors based in gold, which have already been shown to be effective in the detection of carcinogenic cells and tumour biomarkers.

Turning wood into pharmaceutical ingredients 
Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

Active pharmaceutical ingredients can persist in the environment
A study finds trace levels of medicines in drinking water from private wells.

Drug development stakeholders call for improved pharmaceutical testing
Published in Drug Discovery Today, 'Advancing Nonclinical Innovation and Safety in Pharmaceutical Testing' identifies the necessary steps that will lead to safer and more effective medicines, guided by a greater focus on human-based in vitro and in silico methods, which allow scientists to observe human cells, tissues, and biological processes, and their interaction with potential medications.

A step ahead in pharmaceutical research
Researchers of the University of W├╝rzburg have developed a method that makes it possible to measure the activation of receptors in a very short time.

Are pharmaceutical marketing payments to physicians for opioids associated with prescribing?
Pharmaceutical industry marketing of opioid products to physicians through nonresearch payments, which can include speaking fees and meals, was associated with greater opioid prescribing.

Read More: Pharmaceutical Sciences News and Pharmaceutical Sciences Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to